ADVAIR HFA 115-21 MCG INHALER

fluticasone propionate and salmeterol xinafoate
$18.6826per GM

Strength

115; 21 ug/1; ug/1

NDC

00173071622

Classification

Brand

Dosage Form

AEROSOL, METERED

Route

RESPIRATORY (INHALATION)

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021254

On Market Since

9/29/2008

Pharmacological Classes

Adrenergic beta2-Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
beta2-Adrenergic Agonist

Price History

1W

0.0%

1M

-0.2%

3M

-0.1%

6M

-0.2%

1Y

-0.4%

3Y

-29.2%

5Y

-27.9%

All

+6.9%